Vir Biotechnology, Inc.

VIR

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001706431

SEC filings (opens in a new tab)

No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Vir Biotechnology, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of VIR: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	213	2	213	+2
Shares	110.8M	25.7K	107.0M	−3.74M (−3.4%)
Value	$558.5M	$129.4K	$610.8M	+$52.5M (+9.4%)

2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Vir Biotechnology, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to VIR in Q3 2025
Institution	Shares	Value	% of portfolio
Superstring Capital Management LP	150,312	$858.3K	0.85%
Dark Forest Capital Management LP	143,068	$816.9K	0.03%
XTX Topco Ltd	139,896	$798.8K	0.04%
Mirae Asset Global ETFs Holdings Ltd.	105,965	$604.6K	0.00%
Acadian Asset Management LLC	94,801	$539.0K	0.00%
Connective Capital Management, LLC	75,470	$430.9K	0.40%
Jane Street Group, LLC	72,240	$412.5K	0.00%
Winton Group Ltd	57,751	$329.8K	0.01%
Sender Co & Partners, Inc.	43,175	$246.5K	0.10%
Atom Investors LP	33,200	$189.6K	0.01%
Prelude Capital Management, LLC	19,000	$108.5K	0.01%
Jain Global LLC	18,376	$104.9K	0.00%
ISAM Funds (UK) Ltd	17,086	$97.6K	0.02%
Wolverine Trading, LLC	12,141	$68.4K	0.00%
Truist Financial Corp	11,115	$63.5K	0.00%
Rockefeller Capital Management L.P.	10,397	$59.4K	0.00%
FNY Investment Advisers, LLC	6,825	$38.0K	0.01%
Walleye Trading LLC	1,940	$11.1K	0.00%
Global Retirement Partners, LLC	1,500	$8.56K	0.00%
Salomon & Ludwin, LLC	870	$4.99K	0.00%
Aspect Partners, LLC	581	$3.32K	0.00%
Optiver Holding B.V.	456	$2.60K	0.00%
Quadrant Capital Group LLC	182	$1.04K	0.00%
Advisory Services Network, LLC	139	$794	0.00%
Cedar Mountain Advisors, LLC	101	$577	0.00%
Bare Financial Services, Inc	97	$554	0.00%
Massmutual Trust Co FSB	79	$451	0.00%
Salzhauer Michael	4,300	–	–

Sold out (26)

Institutions that held Vir Biotechnology, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of VIR in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Artisan Partners Limited Partnership	791,611	$3.99M
Catalio Capital Management, LP	388,303	$1.96M
ADAR1 Capital Management, LLC	250,000	$1.26M
Graham Capital Management, L.P.	234,614	$1.18M
Trexquant Investment LP	217,355	$1.10M
Verition Fund Management LLC	59,670	$300.7K
Engineers Gate Manager LP	56,730	$285.9K
Ieq Capital, LLC	46,363	$233.7K
Vontobel Holding Ltd.	45,356	$228.6K
Brevan Howard Capital Management LP	34,743	$175.1K
Axq Capital, LP	23,820	$120.1K
Corton Capital Inc.	22,527	$113.5K
Algert Global LLC	19,802	$99.8K
Colony Group, LLC	18,447	$93.0K
Group One Trading, L.P.	13,967	$70.4K
Two Sigma Securities, LLC	13,368	$67.4K
Caption Management, LLC	12,600	$63.5K
Ballentine Partners, LLC	11,743	$59.2K
Skopos Labs, Inc.	9,583	$48.3K
Raymond James Financial Inc	7,018	$35.4K
Leonteq Securities AG	2,700	$13.6K
Headlands Technologies LLC	1,573	$7.93K
GHP Investment Advisors, Inc.	734	$3.70K
MAI Capital Management	124	$625
Hughes Financial Services, LLC	113	$574
Bessemer Group Inc	60	$0

Not filed for Q3 2025 yet (2)

Institutions that held Vir Biotechnology, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VIR in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
E Fund Management Co., Ltd.	14,698	$74.1K
CIBC World Markets Corp	10,974	$55.3K